332 related articles for article (PubMed ID: 15952009)
1. No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients.
Riley J; Ross JR; Rutter D; Wells AU; Goller K; du Bois R; Welsh K
Support Care Cancer; 2006 Jan; 14(1):56-64. PubMed ID: 15952009
[TBL] [Abstract][Full Text] [Related]
2. Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial.
Riley J; Branford R; Droney J; Gretton S; Sato H; Kennett A; Oyebode C; Thick M; Wells A; Williams J; Welsh K; Ross J
J Pain Symptom Manage; 2015 Feb; 49(2):161-72. PubMed ID: 24975432
[TBL] [Abstract][Full Text] [Related]
3. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
[TBL] [Abstract][Full Text] [Related]
5. Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial.
Narabayashi M; Saijo Y; Takenoshita S; Chida M; Shimoyama N; Miura T; Tani K; Nishimura K; Onozawa Y; Hosokawa T; Kamoto T; Tsushima T;
Jpn J Clin Oncol; 2008 Apr; 38(4):296-304. PubMed ID: 18326541
[TBL] [Abstract][Full Text] [Related]
6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
Bruera E; Belzile M; Pituskin E; Fainsinger R; Darke A; Harsanyi Z; Babul N; Ford I
J Clin Oncol; 1998 Oct; 16(10):3222-9. PubMed ID: 9779695
[TBL] [Abstract][Full Text] [Related]
8. A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain.
Watanabe S; Pereira J; Tarumi Y; Hanson J; Bruera E
J Palliat Med; 2008 May; 11(4):570-4. PubMed ID: 18454609
[TBL] [Abstract][Full Text] [Related]
9. Therapy switching in patients receiving long-acting opioids.
Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
[TBL] [Abstract][Full Text] [Related]
10. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial.
Moksnes K; Dale O; Rosland JH; Paulsen O; Klepstad P; Kaasa S
Eur J Cancer; 2011 Nov; 47(16):2463-70. PubMed ID: 21775131
[TBL] [Abstract][Full Text] [Related]
11. The use of oxycodone in cancer-related pain: a literature review.
Cairns R
Int J Palliat Nurs; 2001 Nov; 7(11):522-7. PubMed ID: 11775926
[TBL] [Abstract][Full Text] [Related]
12. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.
Enting RH; Oldenmenger WH; van der Rijt CC; Wilms EB; Elfrink EJ; Elswijk I; Sillevis Smitt PA
Cancer; 2002 Jun; 94(11):3049-56. PubMed ID: 12115396
[TBL] [Abstract][Full Text] [Related]
13. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
[TBL] [Abstract][Full Text] [Related]
14. Opioid switching to improve pain relief and drug tolerability.
Quigley C
Cochrane Database Syst Rev; 2004; (3):CD004847. PubMed ID: 15266542
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of oxycodone in the management of cancer pain.
King SJ; Reid C; Forbes K; Hanks G
Palliat Med; 2011 Jul; 25(5):454-70. PubMed ID: 21708852
[TBL] [Abstract][Full Text] [Related]
16. Prescription and administration of opioids to hospital in-patients, and barriers to effective use.
Murnion BP; Gnjidic D; Hilmer SN
Pain Med; 2010 Jan; 11(1):58-66. PubMed ID: 19930113
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain.
Moksnes K; Kaasa S; Paulsen Ø; Rosland JH; Spigset O; Dale O
Eur J Clin Pharmacol; 2012 Aug; 68(8):1147-56. PubMed ID: 22374345
[TBL] [Abstract][Full Text] [Related]
18. Morphine as first medication for treatment of cancer pain.
Nunes BC; Garcia JB; Sakata RK
Braz J Anesthesiol; 2014; 64(4):236-40. PubMed ID: 24998106
[TBL] [Abstract][Full Text] [Related]
19. Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine.
Kalso E; Simpson KH; Slappendel R; Dejonckheere J; Richarz U
BMC Med; 2007 Dec; 5():39. PubMed ID: 18154644
[TBL] [Abstract][Full Text] [Related]
20. Opioid analgesics for cancer pain: symptom control for the living or comfort for the dying? A qualitative study to investigate the factors influencing the decision to accept morphine for pain caused by cancer.
Reid CM; Gooberman-Hill R; Hanks GW
Ann Oncol; 2008 Jan; 19(1):44-8. PubMed ID: 18073222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]